Day 7 blastocyst live birth linked to prior transfer history, not embryo cohort make-up, ASRM 2026 study reportsIVF.net Newsdesk30 October 2026 |
Live birth after transfer of a day 7 blastocyst was associated with a patient's prior embryo transfer history. The retrospective study was presented at the 2026 American Society for Reproductive Medicine (ASRM) Scientific Congress in Baltimore. US Fertility
The share of day 7 embryos in a patient's cohort was not associated with outcomes, according to the press release from US Fertility. The findings are relevant to labs that extend culture to day 7 and vitrify late blastocysts. US Fertility
The study, from the US Fertility network, included 2,439 frozen embryo transfer (FET) cycles involving a day 7 blastocyst. Of these, 1,318 were first FETs and 1,121 followed a prior FET, grouped by whether that transfer ended in a live birth. US Fertility
The researchers used regression models adjusted for patient age, embryo quality and endometrial thickness. The release does not say whether the percentages below are crude or adjusted. US Fertility
Live birth was 24.1% at a first transfer and 25.2% after a prior transfer that ended in a live birth. The release describes these as similar. After a prior failed transfer, live birth was 18.7%, which the release reports as significantly lower than at a first transfer. US Fertility
Clinical pregnancy loss was also reported as significantly higher after a prior failed transfer: 34.5%, against 24.9% at a first transfer. US Fertility
The release says day 7 blastocysts "are typically treated as a lower-priority option" because of their reduced reproductive potential. It concludes that the findings "suggest a day 7 embryo has real live birth potential", best understood alongside a patient's prior reproductive history. US Fertility
Lead author Dr Jensen Reckhow is an RMA of New York fellow at the Icahn School of Medicine at Mount Sinai. Dr Reckhow said the data "can be used for personalized counseling". US Fertility
Dr Phillip Romanski, associate research director for US Fertility, said clinicians "can factor in a patient's own transfer history to set more realistic expectations". US Fertility
The abstract was presented on 26 October in the congress's prize paper session, according to US Fertility's ASRM 2026 programme page. Its authors are from practices in the US Fertility network. US Fertility
IVF.net notes: this report is based on the US Fertility press release and programme listing, as IVF.net could not open the abstract itself. The release gives no odds ratios, confidence intervals or P values. It does not say whether embryos had preimplantation genetic testing for aneuploidy (PGT-A) or how many were transferred. It reports no comparison with day 5 or day 6 blastocysts. As a retrospective study, it shows associations rather than causes.
IVF.net comment: for labs that extend culture to day 7, the findings bear on counselling rather than culture or grading. It may help to report the lab's own day 7 FET outcomes by first or repeat transfer. Clinicians could then use local figures when counselling. Changes to culture or grading practice may be best left until the full data are published.
Related reading: IVF.net's education pages Blastocyst grading explained and Vitrification and warming: principles and pitfalls.
27 October 2026. US Fertility
October 2026. US Fertility
IVF.net Newsdesk articles are written from the original sources listed above. If you spot an error, please contact IVF.net and we will correct it.
266